Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$114M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$31.3M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$26.4M |
| 4 |
Tyler Technologies
TYL
|
+$25M |
| 5 |
Brown & Brown
BRO
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$249M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Alibaba
BABA
|
+$140M |
| 5 |
Amazon
AMZN
|
+$99.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.49% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.19% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWAV
2376
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $589K | ﹤0.01% |
+13,400
| New | +$495K |
|
2377
Mitek Systems
MITK
$843M
| $588K | ﹤0.01% |
76,800
+2,000
| +3% | +$16.9K |
|
2378
HCI Group
HCI
$2.31B
| $584K | ﹤0.01% |
12,800
| – | – |
|
|
NE
2379
DELISTED
Noble Corporation
NE
| $582K | ﹤0.01% |
476,998
+14,300
| +3% | +$17.1K |
|
2380
Hooker Furnishings Corp
HOFT
$163M
| $581K | ﹤0.01% |
22,600
+700
| +3% | +$16.5K |
|
2381
Construction Partners
ROAD
$6.81B
| $579K | ﹤0.01% |
34,300
+800
| +2% | +$14K |
|
|
RUBY
2382
DELISTED
Rubius Therapeutics, Inc
RUBY
| $579K | ﹤0.01% |
60,900
+1,500
| +3% | +$14.5K |
|
2383
Globalstar
GSAT
$10.8B
| $577K | ﹤0.01% |
74,117
+2,273
| +3% | +$13.7K |
|
2384
Park Aerospace
PKE
$813M
| $574K | ﹤0.01% |
35,300
+1,300
| +4% | +$21.5K |
|
2385
Metallus
MTUS
$910M
| $573K | ﹤0.01% |
72,900
+3,800
| +5% | +$23.8K |
|
|
BVH
2386
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $570K | ﹤0.01% |
23,880
+660
| +3% | +$15.2K |
|
2387
Lifecore Biomedical
LFCR
$187M
| $568K | ﹤0.01% |
50,200
+1,400
| +3% | +$14.9K |
|
2388
Victory Capital Holdings
VCTR
$7.03B
| $566K | ﹤0.01% |
27,000
+2,600
| +11% | +$47.2K |
|
2389
MasterCraft Boat Holdings
MCFT
$605M
| $564K | ﹤0.01% |
35,800
+1,000
| +3% | +$15.8K |
|
2390
MeiraGTx Holdings
MGTX
$1.2B
| $561K | ﹤0.01% |
28,000
+3,200
| +13% | +$54.8K |
|
2391
Greenlight Captial
GLRE
$506M
| $560K | ﹤0.01% |
55,400
+2,200
| +4% | +$22.8K |
|
2392
Green Brick Partners
GRBK
$3.08B
| $556K | ﹤0.01% |
48,400
+1,200
| +3% | +$13.1K |
|
2393
Paysign
PAYS
$718M
| $554K | ﹤0.01% |
+54,600
| New | +$574K |
|
|
HONE
2394
DELISTED
HarborOne Bancorp
HONE
| $553K | ﹤0.01% |
50,284
+2,400
| +5% | +$25.2K |
|
|
LCI
2395
DELISTED
Lannett Company, Inc.
LCI
| $545K | ﹤0.01% |
+15,450
| New | +$628K |
|
|
LL
2396
DELISTED
LL Flooring Holdings, Inc.
LL
| $537K | ﹤0.01% |
55,000
+2,800
| +5% | +$26.2K |
|
|
BGG
2397
DELISTED
Briggs & Stratton Corp.
BGG
| $536K | ﹤0.01% |
80,500
+3,300
| +4% | +$20.3K |
|
2398
Amalgamated Financial
AMAL
$1.5B
| $535K | ﹤0.01% |
27,500
+900
| +3% | +$16.6K |
|
|
RRD
2399
DELISTED
RR Donnelley & Sons Co.
RRD
| $535K | ﹤0.01% |
135,545
+7,200
| +6% | +$28.4K |
|
2400
Titan Machinery
TITN
$442M
| $534K | ﹤0.01% |
36,100
+700
| +2% | +$10.9K |
|
Similar funds
Swiss National Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Swiss National Bank held 2,602 positions worth $97.5B, up 3.6% from $94.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Swiss National Bank withdrew a net $3.98B in Q4 2019, closing 96 positions and reducing 725 holdings. Its most notable exit was Celgene Corp, an estimated $231M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Match Group worth $14.7M.
- Swiss National Bank's largest Q4 2019 buy was Match Group: 179,200 shares worth $14.7M.
- Swiss National Bank added most to Bristol-Myers Squibb in Q4 2019, an estimated $114M increase.
- Swiss National Bank's biggest Q4 2019 reduction was Apple, cutting an estimated $249M.
- Swiss National Bank fully exited Celgene Corp in Q4 2019, selling an estimated $231M.
- Swiss National Bank's ten largest holdings make up 19% of its $97.5B portfolio in Q4 2019.
- Swiss National Bank opened 82 new positions and closed 96 in Q4 2019.
- Swiss National Bank's portfolio value rose 3.6% quarter-over-quarter to $97.5B.
Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.